Inhibikase Therapeutics, Inc.(IKT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

IKT Inhibikase Therapeutics, Inc.

盘前交易 12-23 06:16:21 EST

3.20

+0.04

+1.27%

最高3.50	最低3.07	成交量180.03万
今开3.13	昨收3.16	日振幅13.61%
总市值2.15亿	流通市值3,276万	总股本6,719万
成交额577.16万	换手率17.59%	流通股本1,024万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"IKT","market":"US","secType":"STK","nameCN":"Inhibikase Therapeutics, Inc.","latestPrice":3.2,"timestamp":1734728400000,"preClose":3.16,"halted":0,"volume":1800283,"delay":0,"floatShares":10237218,"shares":67192570,"eps":-2.989894,"marketStatus":"盘前交易","marketStatusCode":1,"change":0.04,"latestTime":"12-23 06:16:21 EST","open":3.13,"high":3.5,"low":3.07,"amount":5771631.686114,"amplitude":0.136076,"askPrice":4,"askSize":500,"bidPrice":2.73,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-2.989894,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734964200000},"adr":0,"listingDate":1608699600000,"adjPreClose":3.2,"postHourTrading":{"tag":"盘后","latestPrice":3.27,"preClose":3.2,"latestTime":"19:22 EST","volume":413125,"amount":1322159.59,"timestamp":1734740558499},"volumeRatio":2.2349632347598787},"requestUrl":"/m/hq/s/IKT","defaultTab":"news","newsList":[{"id":"2493421803","title":"Inhibikase Therapeutics, Inc.盘中异动 急速拉升5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493421803","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493421803?lang=zh_cn&edition=full","pubTime":"2024-12-21 00:59","pubTimestamp":1734713941,"startTime":"0","endTime":"0","summary":"北京时间2024年12月21日00时59分，Inhibikase Therapeutics, Inc.股票出现异动，股价大幅拉升5.06%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.67%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221005901ab87a308&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221005901ab87a308&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IKT","LENZ","BK4139"],"gpt_icon":0},{"id":"2492174771","title":"Inhibikase Therapeutics, Inc.盘中异动 早盘股价大涨5.21%报3.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492174771","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492174771?lang=zh_cn&edition=full","pubTime":"2024-12-19 23:07","pubTimestamp":1734620833,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日23时07分，Inhibikase Therapeutics, Inc.股票出现异动，股价急速拉升5.21%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为3.24%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121923071395ea7ba3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121923071395ea7ba3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IKT","LENZ"],"gpt_icon":0},{"id":"2492184620","title":"Inhibikase Therapeutics, Inc.盘中异动 大幅拉升5.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492184620","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492184620?lang=zh_cn&edition=full","pubTime":"2024-12-18 22:40","pubTimestamp":1734532805,"startTime":"0","endTime":"0","summary":"北京时间2024年12月18日22时40分，Inhibikase Therapeutics, Inc.股票出现异动，股价大幅拉升5.79%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.04%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218224005ab8209b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218224005ab8209b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","IKT"],"gpt_icon":0},{"id":"2492965162","title":"Inhibikase Therapeutics, Inc.盘中异动 早盘大幅上涨7.28%报3.83美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492965162","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492965162?lang=zh_cn&edition=full","pubTime":"2024-12-17 22:39","pubTimestamp":1734446353,"startTime":"0","endTime":"0","summary":"北京时间2024年12月17日22时39分，Inhibikase Therapeutics, Inc.股票出现波动，股价急速上涨7.28%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.84%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217223914984c906f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217223914984c906f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IKT","LENZ","BK4139"],"gpt_icon":0},{"id":"2491692062","title":"Inhibikase Therapeutics, Inc.盘中异动 早盘股价大涨5.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491692062","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491692062?lang=zh_cn&edition=full","pubTime":"2024-12-16 22:33","pubTimestamp":1734359581,"startTime":"0","endTime":"0","summary":"北京时间2024年12月16日22时33分，Inhibikase Therapeutics, Inc.股票出现异动，股价快速上涨5.79%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.30%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216223302ab7c949b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216223302ab7c949b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IKT","LENZ","BK4139"],"gpt_icon":0},{"id":"2491637296","title":"Inhibikase Therapeutics, Inc.盘中异动 大幅上涨5.25%报3.41美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491637296","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491637296?lang=zh_cn&edition=full","pubTime":"2024-12-13 23:58","pubTimestamp":1734105537,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日23时58分，Inhibikase Therapeutics, Inc.股票出现异动，股价急速上涨5.25%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.31%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213235857984bdab3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213235857984bdab3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IKT","BK4139","LENZ"],"gpt_icon":0},{"id":"2490387783","title":"Inhibikase Therapeutics, Inc.盘中异动 早盘股价大涨5.94%报3.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490387783","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490387783?lang=zh_cn&edition=full","pubTime":"2024-12-12 23:06","pubTimestamp":1734015961,"startTime":"0","endTime":"0","summary":"北京时间2024年12月12日23时06分，Inhibikase Therapeutics, Inc.股票出现波动，股价快速上涨5.94%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.56%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121223060195e9386b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121223060195e9386b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IKT","LENZ","BK4139"],"gpt_icon":0},{"id":"2490976863","title":"Inhibikase Therapeutics, Inc.盘中异动 早盘急速拉升5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490976863","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490976863?lang=zh_cn&edition=full","pubTime":"2024-12-11 22:40","pubTimestamp":1733928031,"startTime":"0","endTime":"0","summary":"北京时间2024年12月11日22时40分，Inhibikase Therapeutics, Inc.股票出现异动，股价急速上涨5.31%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.03%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211224031a1e66ee7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211224031a1e66ee7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","IKT","BK4139"],"gpt_icon":0},{"id":"2490177537","title":"Inhibikase Therapeutics, Inc.盘中异动 股价大跌5.18%报3.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490177537","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490177537?lang=zh_cn&edition=full","pubTime":"2024-12-09 22:40","pubTimestamp":1733755256,"startTime":"0","endTime":"0","summary":"北京时间2024年12月09日22时40分，Inhibikase Therapeutics, Inc.股票出现异动，股价急速下跌5.18%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.28%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209224056a1e0ad5c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209224056a1e0ad5c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IKT","LENZ"],"gpt_icon":0},{"id":"2489048237","title":"Inhibikase Therapeutics, Inc.盘中异动 大幅拉升6.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489048237","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489048237?lang=zh_cn&edition=full","pubTime":"2024-12-06 23:57","pubTimestamp":1733500673,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日23时57分，Inhibikase Therapeutics, Inc.股票出现波动，股价快速上涨6.59%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.68%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206235753a1d999dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206235753a1d999dd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","IKT"],"gpt_icon":0},{"id":"2489145458","title":"Inhibikase Therapeutics, Inc.盘中异动 下午盘快速下跌5.00%报2.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489145458","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489145458?lang=zh_cn&edition=full","pubTime":"2024-12-05 03:00","pubTimestamp":1733338836,"startTime":"0","endTime":"0","summary":"北京时间2024年12月05日03时00分，Inhibikase Therapeutics, Inc.股票出现波动，股价急速下挫5.00%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205030036ab5daa17&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205030036ab5daa17&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IKT","LENZ"],"gpt_icon":0},{"id":"2488770156","title":"Inhibikase Therapeutics, Inc.盘中异动 急速上涨6.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488770156","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488770156?lang=zh_cn&edition=full","pubTime":"2024-12-02 22:36","pubTimestamp":1733150184,"startTime":"0","endTime":"0","summary":"北京时间2024年12月02日22时36分，Inhibikase Therapeutics, Inc.股票出现异动，股价急速拉升6.16%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.05%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120222362498e4eb96&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120222362498e4eb96&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","IKT"],"gpt_icon":0},{"id":"2487256383","title":"Inhibikase Therapeutics, Inc.盘中异动 股价大涨5.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2487256383","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2487256383?lang=zh_cn&edition=full","pubTime":"2024-11-29 22:31","pubTimestamp":1732890693,"startTime":"0","endTime":"0","summary":"北京时间2024年11月29日22时31分，Inhibikase Therapeutics, Inc.股票出现波动，股价快速上涨5.49%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.12%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112922313598e46642&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112922313598e46642&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","IKT"],"gpt_icon":0},{"id":"2486088148","title":"Inhibikase Therapeutics, Inc.盘中异动 大幅上涨5.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486088148","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486088148?lang=zh_cn&edition=full","pubTime":"2024-11-27 01:26","pubTimestamp":1732642011,"startTime":"0","endTime":"0","summary":"北京时间2024年11月27日01时26分，Inhibikase Therapeutics, Inc.股票出现波动，股价快速拉升5.54%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127012652971a8b0d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127012652971a8b0d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IKT","LENZ"],"gpt_icon":0},{"id":"2486038844","title":"Inhibikase Therapeutics, Inc.盘中异动 早盘快速拉升5.19%报2.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486038844","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486038844?lang=zh_cn&edition=full","pubTime":"2024-11-25 22:33","pubTimestamp":1732545185,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日22时33分，Inhibikase Therapeutics, Inc.股票出现波动，股价大幅上涨5.19%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.06%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125223305a2548d36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125223305a2548d36&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IKT","LENZ","BK4139"],"gpt_icon":0},{"id":"2485329454","title":"Inhibikase Therapeutics, Inc.盘中异动 股价大涨5.97%报2.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485329454","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485329454?lang=zh_cn&edition=full","pubTime":"2024-11-23 01:39","pubTimestamp":1732297180,"startTime":"0","endTime":"0","summary":"北京时间2024年11月23日01时39分，Inhibikase Therapeutics, Inc.股票出现异动，股价急速拉升5.97%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.76%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112301394098e4435e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112301394098e4435e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","IKT","BK4139"],"gpt_icon":0},{"id":"2485549713","title":"Inhibikase Therapeutics, Inc.盘中异动 急速跳水6.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485549713","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485549713?lang=zh_cn&edition=full","pubTime":"2024-11-21 22:40","pubTimestamp":1732200053,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日22时40分，Inhibikase Therapeutics, Inc.股票出现异动，股价快速下挫6.57%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.32%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121224054971a7e35&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121224054971a7e35&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","IKT","BK4139"],"gpt_icon":0},{"id":"2485429125","title":"Inhibikase Therapeutics, Inc.盘中异动 股价大跌5.00%报1.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485429125","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485429125?lang=zh_cn&edition=full","pubTime":"2024-11-21 02:19","pubTimestamp":1732126743,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日02时19分，Inhibikase Therapeutics, Inc.股票出现异动，股价快速下挫5.00%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.52%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112102190498e43cb1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112102190498e43cb1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IKT","BK4139","LENZ"],"gpt_icon":0},{"id":"2483804503","title":"Inhibikase Therapeutics, Inc.盘中异动 早盘急速下跌6.20%报2.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483804503","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483804503?lang=zh_cn&edition=full","pubTime":"2024-11-14 22:48","pubTimestamp":1731595732,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日22时48分，Inhibikase Therapeutics, Inc.股票出现波动，股价急速下跌6.20%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.57%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114224852abc16444&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114224852abc16444&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","IKT"],"gpt_icon":0},{"id":"2482085765","title":"Inhibikase Therapeutics, Inc.盘中异动 股价大跌5.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482085765","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482085765?lang=zh_cn&edition=full","pubTime":"2024-11-12 22:32","pubTimestamp":1731421950,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日22时32分，Inhibikase Therapeutics, Inc.股票出现异动，股价快速跳水5.92%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112223231971a5fe5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112223231971a5fe5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","IKT"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.inhibikase.com","stockEarnings":[{"period":"1week","weight":-0.0698},{"period":"1month","weight":0.6162},{"period":"3month","weight":1.6667},{"period":"6month","weight":1.2857},{"period":"1year","weight":1.5397},{"period":"ytd","weight":1.5197}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Inhibikase Therapeutics, Inc.于2010年6月3日注册为特拉华州公司。该公司是一家临床阶段制药公司，致力于开发针对帕金森氏病或PD以及大脑内外发生的相关疾病的疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.425952},{"month":2,"riseRate":0.5,"avgChangeRate":-0.118451},{"month":3,"riseRate":0.25,"avgChangeRate":0.045803},{"month":4,"riseRate":0,"avgChangeRate":-0.217435},{"month":5,"riseRate":0.75,"avgChangeRate":0.088455},{"month":6,"riseRate":0,"avgChangeRate":-0.283409},{"month":7,"riseRate":0.5,"avgChangeRate":-0.045361},{"month":8,"riseRate":0.5,"avgChangeRate":-0.009087},{"month":9,"riseRate":0,"avgChangeRate":-0.157472},{"month":10,"riseRate":0.5,"avgChangeRate":0.119822},{"month":11,"riseRate":0.75,"avgChangeRate":0.000349},{"month":12,"riseRate":0.5,"avgChangeRate":0.002932}],"exchange":"NASDAQ","name":"Inhibikase Therapeutics, Inc.","nameEN":"Inhibikase Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Inhibikase Therapeutics, Inc.(IKT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Inhibikase Therapeutics, Inc.(IKT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Inhibikase Therapeutics, Inc.,IKT,Inhibikase Therapeutics, Inc.股票,Inhibikase Therapeutics, Inc.股票老虎,Inhibikase Therapeutics, Inc.股票老虎国际,Inhibikase Therapeutics, Inc.行情,Inhibikase Therapeutics, Inc.股票行情,Inhibikase Therapeutics, Inc.股价,Inhibikase Therapeutics, Inc.股市,Inhibikase Therapeutics, Inc.股票价格,Inhibikase Therapeutics, Inc.股票交易,Inhibikase Therapeutics, Inc.股票购买,Inhibikase Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Inhibikase Therapeutics, Inc.(IKT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Inhibikase Therapeutics, Inc.(IKT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}